Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 28, 1998 - Issue 1
27
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics, metabolism and pharmacodynamic s of a benzimidazole angiotensin II type 1 receptor antagonist in the beagle dog and cynomologus monkey

&
Pages 77-91 | Published online: 22 Sep 2008

References

  • CHRIST, D. D., KILKSON, T., WONG, N. and Li, G. N., 1990, Formation and dispositionof EXP3174, a pharmacologicaly active metabolite of the novel angiotensin II receptor antagonist Dup 753. Abstract of the 3rd North America Meeting of the International Society for the Study of Xenobiotics, 137.
  • CHRIST, D. D., WONG, P. C., WONG, N.Y., HART, S. D., QUON, C. Y. and LAM, G. N., 1994, The pharmacokineties and pharmacodynam im of the angiotensin II receptor antagonist losartan potassium (D up 753/MK 954)in the dog. journal of Pharmacology and Experimental Therapeutics, 268, 1199–1205.
  • DAVIES, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 10, 1093–1095.
  • GIBALDI, M. and PERRIER, D., 1982, Pharmacokinetk s, 2nd edn (New York: Marcel Dekker).
  • KAKIKI, M. and HOR1E, T., 1996, Localization of a novel non-peptide angiotensin II type 1 receptor antagonist, E4177, in rat adrenal glomerulosa. Biological and Pharmaceutical Bulletin, 19, 1357–1361.
  • KAKIKI, M. and TADANKO, K., 1997, Localization and disposition of a non-peptide angiotensin II type 1 receptor antagonist, and its glucuronide metabolite, in rat. Xenobiotka, 27, 723–732.
  • LOKUTA, A. J., COOPER, C., GAA, S. T., WANG, H. E. and ROGERS, T. B., 1994, AngiotensinI I stimulates the release of phospholipid-derived second messengers through multiple receptor subtypes in heart cells. Journal of Biological Chemistry, 269, 4832–4838.
  • MUKOYAMA, M., NAKAJIMA, M., HORIUCHI, M., SASAMURA, H., PRATT, R. E. and DZAU, V. J., 1993, Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transm embrane receptors. journal of Biological Chemistry, 268, 24539–24542.
  • MUNAFO, A., CHRISTEN, Y., NUSSBERGER J., SHUM, L. Y., BORLAND, R. M., LEE, R. J., WAEBER, B., BIOLLAZ, J. and BRUNNER, H. R., 1992, Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clinical Pharmacology and Therapeutics, 51, 513–521.
  • OHTAWA M., TAKAYAMA, F., SAITOH, K., YOSHINAGA, T. and NAKASHIMA, M., 1993, Pharmacokinetics and biochemicalefficacy after single and multiple oral administrationof losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans. British Journal of Clinical Phar-macology, 35, 290–297.
  • SANDBERG, K., J1, H., CLARK, A. J. L, SHAPIRA, H. and CATT, K. J., 1992, Cloning and expression of a novel angiotensin II receptors subtype. Journal of Biological Chemistry, 267, 9455–9458.
  • SONG, K., SHIOTA, N., OKUNISHI, H. and MrrAzmo, M., 1992, Nephrectomy and a newly identified binding site for angiotensin II in the rat adrenal cortex. Life Sciences, 51, PL165–170.
  • TIMMERMANS, P. B. M. W. M., Cmu, A. T., HERBLIN W. F., WONG, P. C., and SMITH, R. D., 1992, Angiotensin II receptor subtypes. American Journal of Hypertension, 5, 406–410.
  • YAMAOKA, K., NAKAGAWA, T. and UNO, T., 1978, Statistical moments in pharmacokinetics. Journal of Pharmacokinetic s and Biopharmaceutk s, 6, 547–558.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.